The electrocardiogram (ecg) telemetry devices market size has grown strongly in recent years. It will grow from $4.5 billion in 2025 to $4.88 billion in 2026 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to limited access to remote monitoring technologies, reliance on hospital-based ECG monitoring, growing prevalence of cardiovascular diseases, expansion of outpatient care, increasing awareness of arrhythmia management.
The electrocardiogram (ecg) telemetry devices market size is expected to see strong growth in the next few years. It will grow to $6.72 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to advancement in wireless mobile cardiac telemetry, adoption of miniaturized implantable loop recorders, increasing integration of AI and predictive analytics, growth of home healthcare services, expansion of cloud-enabled ECG monitoring platforms. Major trends in the forecast period include rising adoption of remote cardiac monitoring solutions, integration of cloud-based ecg data management, growing demand for home healthcare cardiac telemetry, increased use of wearable and patch-based ecg devices, focus on early detection and management of cardiovascular disorders.
The rising burden of cardiovascular diseases is increasingly supporting the expansion of the electrocardiogram (ECG) telemetry devices market going forward. Cardiovascular diseases (CVDs) include a group of disorders that affect the heart and blood vessels, such as coronary artery disease, heart failure, and stroke. The growing burden of cardiovascular diseases can be linked to unhealthy dietary patterns, lack of physical activity, tobacco consumption, excessive alcohol intake, air pollution, and socioeconomic factors including stress and poverty. ECG telemetry devices strengthen cardiovascular care by enabling continuous and real-time monitoring, facilitating remote and home-based care, improving the performance of implantable devices, supporting accurate diagnosis and personalized treatment, and enabling timely emergency interventions. For example, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease rose to 233.3 per 100,000 in 2024, representing a 4% increase from 224.4 per 100,000 in 2023. As a result, the rising burden of cardiovascular diseases is significantly contributing to the expansion of the electrocardiogram (ECG) telemetry devices market.
Leading companies operating in the electrocardiogram (ECG) telemetry devices market are developing innovative solutions, such as AI-powered ECG systems, to improve diagnostic accuracy, enable real-time monitoring, and enhance overall cardiovascular care. AI-powered ECG systems integrate traditional electrocardiography with artificial intelligence algorithms to support advanced detection and interpretation of cardiac activity. For example, in July 2025, AliveCor Inc., a US-based mobile ECG technology provider, launched the Kardia 12L, an AI-enabled 12-lead ECG system for clinical and remote use. The device features a portable design with wireless connectivity, enabling rapid acquisition of 12-lead ECGs. AI-driven analytics detect arrhythmias, myocardial infarction risk, and other abnormalities while providing real-time reports and seamless integration with electronic health records and telehealth platforms.
In May 2024, WearLinq Inc., a US-based provider of wearable health monitoring solutions, acquired AMI Cardiac Monitoring LLC for an undisclosed amount. With this acquisition, WearLinq aims to broaden access to its FDA 510(k)-cleared eWave 6-lead ECG monitor and expand its nationwide ambulatory cardiac monitoring capabilities. AMI Cardiac Monitoring LLC is a US-based provider of cardiac monitoring devices and related services.
Major companies operating in the electrocardiogram (ecg) telemetry devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., General Electric Company, Boston Scientific Corporation, Merit Medical Systems Inc., MicroPort Scientific Corporation, AtriCure Inc., Stereotaxis Inc., Kardium Inc., Hansen Medical Inc., Acutus Medical Inc., Imricor Medical Systems Inc., Osypka Medical GmbH, Biotronik SE & Co KG, Japan Lifeline Co Ltd, CardioFocus Inc, CathRx Ltd, Baylis Medical Company Inc, Ablacon Inc, Adagio Medical Inc, VytronUS Inc.
North America was the largest region in the electrocardiogram (ECG) telemetry devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the electrocardiogram (ecg) telemetry devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the electrocardiogram (ecg) telemetry devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the ECG telemetry devices market by increasing costs for imported electronic components, wireless modules, and miniaturized sensors. Segments like implantable loop recorders and wearable patch-based ECG devices are most affected, particularly in Asia-Pacific regions such as China and India, which are major manufacturing hubs. This has led to higher production costs and supply chain challenges. On the positive side, tariffs have encouraged local manufacturing, investment in domestic R&D, and innovation in cost-efficient ECG telemetry solutions.
The electrocardiogram (ecg) telemetry devices market research report is one of a series of new reports that provides electrocardiogram (ecg) telemetry devices market statistics, including electrocardiogram (ecg) telemetry devices industry global market size, regional shares, competitors with a electrocardiogram (ecg) telemetry devices market share, detailed electrocardiogram (ecg) telemetry devices market segments, market trends and opportunities, and any further data you may need to thrive in the electrocardiogram (ecg) telemetry devices industry. This electrocardiogram (ecg) telemetry devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Electrocardiogram (ECG) telemetry devices remotely monitor and record the electrical activity of the heart over time. They are essential for diagnosing and managing heart rhythm problems, heart attacks, and other cardiac disorders by providing continuous, real-time cardiac information.
The main product categories of electrocardiogram (ECG) telemetry devices include event monitoring and mobile cardiac telemetry devices, implantable loop recorders, and others. Event monitoring and mobile cardiac telemetry devices are designed to record the heart’s electrical signals over a defined time period, particularly during symptomatic events such as palpitations or dizziness. These devices are used for applications including arrhythmias, myocardial ischemia and infarction, and pacemaker monitoring, and are utilized by end users such as hospitals and home healthcare providers.
The electrocardiogram (ECG) telemetry devices market consists of sales of ECG devices, stress ECG devices, holter monitors, event monitoring systems, and ECG management systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The electrocardiogram (ecg) telemetry devices market size is expected to see strong growth in the next few years. It will grow to $6.72 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to advancement in wireless mobile cardiac telemetry, adoption of miniaturized implantable loop recorders, increasing integration of AI and predictive analytics, growth of home healthcare services, expansion of cloud-enabled ECG monitoring platforms. Major trends in the forecast period include rising adoption of remote cardiac monitoring solutions, integration of cloud-based ecg data management, growing demand for home healthcare cardiac telemetry, increased use of wearable and patch-based ecg devices, focus on early detection and management of cardiovascular disorders.
The rising burden of cardiovascular diseases is increasingly supporting the expansion of the electrocardiogram (ECG) telemetry devices market going forward. Cardiovascular diseases (CVDs) include a group of disorders that affect the heart and blood vessels, such as coronary artery disease, heart failure, and stroke. The growing burden of cardiovascular diseases can be linked to unhealthy dietary patterns, lack of physical activity, tobacco consumption, excessive alcohol intake, air pollution, and socioeconomic factors including stress and poverty. ECG telemetry devices strengthen cardiovascular care by enabling continuous and real-time monitoring, facilitating remote and home-based care, improving the performance of implantable devices, supporting accurate diagnosis and personalized treatment, and enabling timely emergency interventions. For example, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease rose to 233.3 per 100,000 in 2024, representing a 4% increase from 224.4 per 100,000 in 2023. As a result, the rising burden of cardiovascular diseases is significantly contributing to the expansion of the electrocardiogram (ECG) telemetry devices market.
Leading companies operating in the electrocardiogram (ECG) telemetry devices market are developing innovative solutions, such as AI-powered ECG systems, to improve diagnostic accuracy, enable real-time monitoring, and enhance overall cardiovascular care. AI-powered ECG systems integrate traditional electrocardiography with artificial intelligence algorithms to support advanced detection and interpretation of cardiac activity. For example, in July 2025, AliveCor Inc., a US-based mobile ECG technology provider, launched the Kardia 12L, an AI-enabled 12-lead ECG system for clinical and remote use. The device features a portable design with wireless connectivity, enabling rapid acquisition of 12-lead ECGs. AI-driven analytics detect arrhythmias, myocardial infarction risk, and other abnormalities while providing real-time reports and seamless integration with electronic health records and telehealth platforms.
In May 2024, WearLinq Inc., a US-based provider of wearable health monitoring solutions, acquired AMI Cardiac Monitoring LLC for an undisclosed amount. With this acquisition, WearLinq aims to broaden access to its FDA 510(k)-cleared eWave 6-lead ECG monitor and expand its nationwide ambulatory cardiac monitoring capabilities. AMI Cardiac Monitoring LLC is a US-based provider of cardiac monitoring devices and related services.
Major companies operating in the electrocardiogram (ecg) telemetry devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., General Electric Company, Boston Scientific Corporation, Merit Medical Systems Inc., MicroPort Scientific Corporation, AtriCure Inc., Stereotaxis Inc., Kardium Inc., Hansen Medical Inc., Acutus Medical Inc., Imricor Medical Systems Inc., Osypka Medical GmbH, Biotronik SE & Co KG, Japan Lifeline Co Ltd, CardioFocus Inc, CathRx Ltd, Baylis Medical Company Inc, Ablacon Inc, Adagio Medical Inc, VytronUS Inc.
North America was the largest region in the electrocardiogram (ECG) telemetry devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the electrocardiogram (ecg) telemetry devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the electrocardiogram (ecg) telemetry devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the ECG telemetry devices market by increasing costs for imported electronic components, wireless modules, and miniaturized sensors. Segments like implantable loop recorders and wearable patch-based ECG devices are most affected, particularly in Asia-Pacific regions such as China and India, which are major manufacturing hubs. This has led to higher production costs and supply chain challenges. On the positive side, tariffs have encouraged local manufacturing, investment in domestic R&D, and innovation in cost-efficient ECG telemetry solutions.
The electrocardiogram (ecg) telemetry devices market research report is one of a series of new reports that provides electrocardiogram (ecg) telemetry devices market statistics, including electrocardiogram (ecg) telemetry devices industry global market size, regional shares, competitors with a electrocardiogram (ecg) telemetry devices market share, detailed electrocardiogram (ecg) telemetry devices market segments, market trends and opportunities, and any further data you may need to thrive in the electrocardiogram (ecg) telemetry devices industry. This electrocardiogram (ecg) telemetry devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Electrocardiogram (ECG) telemetry devices remotely monitor and record the electrical activity of the heart over time. They are essential for diagnosing and managing heart rhythm problems, heart attacks, and other cardiac disorders by providing continuous, real-time cardiac information.
The main product categories of electrocardiogram (ECG) telemetry devices include event monitoring and mobile cardiac telemetry devices, implantable loop recorders, and others. Event monitoring and mobile cardiac telemetry devices are designed to record the heart’s electrical signals over a defined time period, particularly during symptomatic events such as palpitations or dizziness. These devices are used for applications including arrhythmias, myocardial ischemia and infarction, and pacemaker monitoring, and are utilized by end users such as hospitals and home healthcare providers.
The electrocardiogram (ECG) telemetry devices market consists of sales of ECG devices, stress ECG devices, holter monitors, event monitoring systems, and ECG management systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Electrocardiogram (ECG) Telemetry Devices Market Characteristics
3. Electrocardiogram (ECG) Telemetry Devices Market Supply Chain Analysis
4. Global Electrocardiogram (ECG) Telemetry Devices Market Trends and Strategies
5. Electrocardiogram (ECG) Telemetry Devices Market Analysis of End Use Industries
7. Global Electrocardiogram (ECG) Telemetry Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Electrocardiogram (ECG) Telemetry Devices Total Addressable Market (TAM) Analysis for the Market
9. Electrocardiogram (ECG) Telemetry Devices Market Segmentation
10. Electrocardiogram (ECG) Telemetry Devices Market Regional and Country Analysis
11. Asia-Pacific Electrocardiogram (ECG) Telemetry Devices Market
12. China Electrocardiogram (ECG) Telemetry Devices Market
13. India Electrocardiogram (ECG) Telemetry Devices Market
14. Japan Electrocardiogram (ECG) Telemetry Devices Market
15. Australia Electrocardiogram (ECG) Telemetry Devices Market
16. Indonesia Electrocardiogram (ECG) Telemetry Devices Market
17. South Korea Electrocardiogram (ECG) Telemetry Devices Market
18. Taiwan Electrocardiogram (ECG) Telemetry Devices Market
19. South East Asia Electrocardiogram (ECG) Telemetry Devices Market
20. Western Europe Electrocardiogram (ECG) Telemetry Devices Market
21. UK Electrocardiogram (ECG) Telemetry Devices Market
22. Germany Electrocardiogram (ECG) Telemetry Devices Market
23. France Electrocardiogram (ECG) Telemetry Devices Market
24. Italy Electrocardiogram (ECG) Telemetry Devices Market
25. Spain Electrocardiogram (ECG) Telemetry Devices Market
26. Eastern Europe Electrocardiogram (ECG) Telemetry Devices Market
27. Russia Electrocardiogram (ECG) Telemetry Devices Market
28. North America Electrocardiogram (ECG) Telemetry Devices Market
29. USA Electrocardiogram (ECG) Telemetry Devices Market
30. Canada Electrocardiogram (ECG) Telemetry Devices Market
31. South America Electrocardiogram (ECG) Telemetry Devices Market
32. Brazil Electrocardiogram (ECG) Telemetry Devices Market
33. Middle East Electrocardiogram (ECG) Telemetry Devices Market
34. Africa Electrocardiogram (ECG) Telemetry Devices Market
36. Electrocardiogram (ECG) Telemetry Devices Market Competitive Landscape and Company Profiles
37. Electrocardiogram (ECG) Telemetry Devices Market Other Major and Innovative Companies
40. Electrocardiogram (ECG) Telemetry Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Electrocardiogram (ECG) Telemetry Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses electrocardiogram (ecg) telemetry devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for electrocardiogram (ecg) telemetry devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The electrocardiogram (ecg) telemetry devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Event Monitoring And Mobile Cardiac Telemetry; Implantable Loop Recorders; Other Products2) By Application: Arrhythmias; Myocardial Ischemia and Infarction; Pacemaker Monitoring; Other Applications
3) By End-User: Hospitals; Home Healthcare
Subsegments:
1) By Event Monitoring And Mobile Cardiac Telemetry: Handheld Event Monitors; Wireless Mobile Cardiac Telemetry Devices; Real-Time Event Monitors; Patch-Based Event Monitors; Mobile ECG Telemetry Systems With Cloud Integration2) By Implantable Loop Recorders: Subcutaneous Implantable Loop Recorders (ILRs); Wireless Implantable Loop Recorders; Long-Term Monitoring Implantable Loop Recorders; Miniaturized Implantable Loop Recorders; Remote Monitoring Implantable Loop Recorders
3) By Other Products: Holter Monitors; Wireless ECG Monitors; Smart Wearable ECG Devices; Patch-Based ECG Monitors; Portable ECG Telemetry Devices
Companies Mentioned: Johnson & Johnson; Abbott Laboratories; Medtronic plc; Siemens Healthineers AG; Koninklijke Philips N.V.; General Electric Company; Boston Scientific Corporation; Merit Medical Systems Inc.; MicroPort Scientific Corporation; AtriCure Inc.; Stereotaxis Inc.; Kardium Inc.; Hansen Medical Inc.; Acutus Medical Inc.; Imricor Medical Systems Inc.; Osypka Medical GmbH; Biotronik SE & Co KG; Japan Lifeline Co Ltd; CardioFocus Inc; CathRx Ltd; Baylis Medical Company Inc; Ablacon Inc; Adagio Medical Inc; VytronUS Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Electrocardiogram (ECG) Telemetry Devices market report include:- Johnson & Johnson
- Abbott Laboratories
- Medtronic plc
- Siemens Healthineers AG
- Koninklijke Philips N.V.
- General Electric Company
- Boston Scientific Corporation
- Merit Medical Systems Inc.
- MicroPort Scientific Corporation
- AtriCure Inc.
- Stereotaxis Inc.
- Kardium Inc.
- Hansen Medical Inc.
- Acutus Medical Inc.
- Imricor Medical Systems Inc.
- Osypka Medical GmbH
- Biotronik SE & Co KG
- Japan Lifeline Co Ltd
- CardioFocus Inc
- CathRx Ltd
- Baylis Medical Company Inc
- Ablacon Inc
- Adagio Medical Inc
- VytronUS Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 4.88 Billion |
| Forecasted Market Value ( USD | $ 6.72 Billion |
| Compound Annual Growth Rate | 8.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
